An existing drug primarily used to treat rheumatoid arthritis could offer a significant new treatment avenue for individuals battling difficult-to-treat depression, a recent study suggests.
Researchers have for the first time explored whether tocilizumab, an anti-inflammatory medication, could alleviate symptoms in patients unresponsive to standard antidepressant therapies.